Viewing Study NCT00371735


Ignite Creation Date: 2025-12-24 @ 10:23 PM
Ignite Modification Date: 2025-12-25 @ 7:55 PM
Study NCT ID: NCT00371735
Status: COMPLETED
Last Update Posted: 2016-12-05
First Post: 2006-09-01
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Chlorproguanil-Dapsone-Artesunate (CDA) Versus Chlorproguanil-Dapsone (LAPDAP) For Uncomplicated Malaria
Sponsor: GlaxoSmithKline
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module